Recombinant Prochlorococcus marinus subsp. pastoris Protein CrcB homolog 1 (crcB1)

Shipped with Ice Packs
In Stock

Description

Production and Purification

The protein is expressed in E. coli and purified via affinity chromatography due to its His-tag. Critical parameters include:

ParameterDetailsSource
Expression HostE. coli
Purity>90% (SDS-PAGE verified)
Storage BufferTris/PBS-based buffer with 6% trehalose, pH 8.0
ReconstitutionDeionized sterile water (0.1–1.0 mg/mL) with 5–50% glycerol for stability

Best Practices: Avoid repeated freeze-thaw cycles; store at -20°C/-80°C .

Key Observations:

  • Sequence Homology: Shares structural motifs with bacterial CrcB proteins, which regulate fluoride efflux .

  • Ecological Context: Prochlorococcus subsp. pastoris (high-light-adapted) thrives in nutrient-poor marine environments, suggesting potential roles in ion homeostasis .

  • Genome Context: Part of the crcB1 gene cluster in Prochlorococcus genomes, which may include regulatory elements for stress response .

Research Applications and Potential

While direct studies on crcB1 are sparse, its recombinant form is utilized in:

  1. Structural Biology: X-ray crystallography to resolve transport mechanism hypotheses.

  2. Biotechnology: Development of fluoride-resistant microbial strains.

  3. Ecological Studies: Exploring ion transport adaptations in marine cyanobacteria .

Comparative Analysis of Recombinant Versions

Below is a comparison of recombinant crcB1 from different Prochlorococcus strains:

StrainUniProt IDLengthKey DifferenceSource
P. marinus subsp. pastorisQ7UZM71–109aaN-terminal His-tag; shorter C-terminal region
P. marinus (NATL2A)Q46IH81–114aaExtended C-terminal sequence; distinct AA sequence

Open Questions and Future Directions

  1. Functional Validation: Confirming fluoride transport activity via electrophysiological assays.

  2. Evolutionary Significance: Investigating crcB1’s role in Prochlorococcus adaptation to marine environments.

  3. Biotechnological Utility: Engineering crcB1 for industrial fluoride remediation.

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have specific format requirements, please indicate them when placing your order. We will fulfill your request as best as possible.
Lead Time
Delivery time may vary depending on the purchase method or location. Please consult your local distributors for specific delivery timeframes.
Note: All protein shipments are standardly accompanied by blue ice packs. If you require dry ice packaging, please communicate this to us in advance. Additional fees may apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial before opening to ensure the contents settle at the bottom. Please reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
The shelf life is influenced by various factors, including storage conditions, buffer components, temperature, and the protein's inherent stability.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process.
The tag type will be determined during the production process. If you have a specific tag type in mind, please inform us. We will prioritize the development of your specified tag type.
Synonyms
crcB1; PMM1631; Putative fluoride ion transporter CrcB 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-109
Protein Length
full length protein
Species
Prochlorococcus marinus subsp. pastoris (strain CCMP1986 / NIES-2087 / MED4)
Target Names
crcB1
Target Protein Sequence
MNKKYLLTFLLTAYCATFLRFYFKNNFVISIIGSFLYGFFISRKISKSKKEILFSGFFAC FTSFSGFVHFLYQFIIQGYYLKLFIYLNVIVILNLIIMYIGFQLSRKIT
Uniprot No.

Target Background

Function
Crucial for reducing fluoride concentration within the cell, thus mitigating its toxicity.
Database Links

KEGG: pmm:PMM1631

STRING: 59919.PMM1631

Protein Families
CrcB (TC 9.B.71) family
Subcellular Location
Cell inner membrane; Multi-pass membrane protein.

Q&A

What is Prochlorococcus marinus subsp. pastoris Protein CrcB homolog 1 (crcB1) and what are its basic structural properties?

Prochlorococcus marinus subsp. pastoris Protein CrcB homolog 1 (crcB1) is a membrane protein found in the marine cyanobacterium Prochlorococcus marinus subsp. pastoris (strain CCMP1986/MED4). The protein is 109 amino acids in length with the UniProt accession number Q7UZM7. The amino acid sequence is characterized by hydrophobic regions consistent with a membrane-spanning protein: MNKKYLLTFLLTAYCATFLRFYFKNNFVISIIGSFLYGFFISRKISKSKKEILFSGFFACFTSFSGFVHFLYQFIIQGYYLKLFIYLNVIVILNLIIMYIGFQLSRKIT . CrcB homologs are generally involved in ion transport, particularly fluoride ion channels, suggesting a role in maintaining ion homeostasis in the bacterial cell.

How is recombinant crcB1 typically stored and what buffer conditions are optimal for maintaining stability?

Recombinant crcB1 protein is typically stored in a Tris-based buffer containing 50% glycerol to maintain stability . For long-term storage, the protein should be kept at -20°C or -80°C. Working aliquots can be maintained at 4°C for up to one week . Repeated freeze-thaw cycles should be avoided as they can lead to protein degradation and loss of functionality. When designing experiments, it's advisable to prepare small working aliquots from the main stock to minimize freeze-thaw cycles. The optimal pH range for maintaining stability is typically 7.0-8.0, though this may vary depending on the specific experimental requirements.

What expression systems are most effective for producing recombinant crcB1 protein?

Based on research on recombinant protein production, the accessibility of translation initiation sites significantly impacts successful protein expression . For membrane proteins like crcB1, E. coli expression systems are commonly used but require optimization. When expressing crcB1, researchers should consider:

  • Codon optimization for the host organism, particularly for the first nine codons, which can significantly impact expression levels

  • Proper signal sequences for membrane protein targeting

  • Moderation of expression rates to prevent inclusion body formation

  • Use of specialized E. coli strains designed for membrane protein expression

The success rate of recombinant protein expression in E. coli is approximately 50%, with factors such as mRNA accessibility of translation initiation sites playing a crucial role in determining expression success . Using tools like TIsigner that modify codons to optimize accessibility can improve expression outcomes by making synonymous substitutions in the initial coding regions .

What are the optimal protocols for purifying recombinant crcB1 protein while maintaining its native conformation?

For membrane proteins like crcB1, maintaining native conformation during purification requires specialized protocols:

  • Cell Lysis and Membrane Fraction Isolation:

    • Use gentle lysis methods (osmotic shock or enzymatic digestion)

    • Isolate membrane fractions through differential centrifugation (10,000×g to remove debris, followed by 100,000×g to collect membranes)

  • Detergent Solubilization:

    • Screen multiple detergents (n-dodecyl β-D-maltoside, digitonin, CHAPS)

    • Typical concentrations: 1-2% for extraction, 0.1-0.5% for purification steps

  • Affinity Chromatography:

    • Utilize the tag incorporated during recombinant expression (His-tag is common)

    • Include detergent in all buffers at concentrations above critical micelle concentration

  • Quality Assessment:

    • Size exclusion chromatography to verify monodispersity

    • Circular dichroism to confirm secondary structure integrity

For crcB1 specifically, mild detergents like DDM (n-dodecyl β-D-maltoside) at 1% for extraction and 0.05% for purification steps often yield the best results while preserving functional conformation.

What methods are most effective for assessing the functional activity of recombinant crcB1 protein?

Since crcB homologs typically function as ion channels (particularly for fluoride ions), the following functional assays are recommended:

  • Liposome Reconstitution Assays:

    • Reconstitute purified crcB1 into liposomes loaded with ion-sensitive fluorescent dyes

    • Measure ion flux using fluorescence quenching or enhancement

  • Patch Clamp Electrophysiology:

    • For direct measurement of ion channel activity

    • Requires reconstitution into planar lipid bilayers or expression in suitable cell systems

  • Isothermal Titration Calorimetry (ITC):

    • Quantify binding of potential ligands or ions

    • Determine binding constants and thermodynamic parameters

  • Ion Flux Assays in Whole Cells:

    • Express crcB1 in cells lacking endogenous fluoride transporters

    • Measure fluoride uptake using fluoride-sensitive electrodes or radioactive tracers

The choice of method should be guided by the specific research question and available equipment. A combination of approaches provides the most comprehensive functional characterization.

What are the recommended ELISA protocols for detecting recombinant crcB1 protein in experimental samples?

For ELISA detection of recombinant crcB1, the following protocol is recommended:

Direct ELISA Protocol for crcB1 Detection:

  • Coating:

    • Dilute samples in carbonate buffer (pH 9.6)

    • Add 100 μL/well to high-binding ELISA plates

    • Incubate overnight at 4°C

  • Blocking:

    • 5% BSA in PBS with 0.1% Tween-20 (PBST)

    • Incubate 2 hours at room temperature

  • Primary Antibody:

    • Anti-crcB1 or anti-tag antibody (1:1000-1:5000 in 1% BSA/PBST)

    • Incubate 2 hours at room temperature

  • Secondary Antibody:

    • HRP-conjugated secondary antibody (1:5000 in 1% BSA/PBST)

    • Incubate 1 hour at room temperature

  • Detection:

    • TMB substrate solution

    • Stop reaction with 2N H₂SO₄

    • Read absorbance at 450 nm

For membrane proteins like crcB1, adding 0.01-0.05% suitable detergent (e.g., DDM) to all buffers can improve detection sensitivity by preventing protein aggregation .

How can recombinant crcB1 protein be utilized in structural biology studies?

Structural characterization of membrane proteins like crcB1 presents unique challenges and opportunities:

  • X-ray Crystallography:

    • Requires crystallization in lipidic cubic phases or with detergent micelles

    • Typically requires 5-10 mg of highly pure (>95%) protein

    • May require protein engineering to improve crystal contacts

  • Cryo-Electron Microscopy:

    • Increasingly preferred for membrane proteins

    • Can visualize protein in detergent micelles or nanodiscs

    • Requires 50-100 μg of protein at 1-2 mg/mL concentration

  • NMR Spectroscopy:

    • Most suitable for specific domains rather than full-length membrane proteins

    • Requires isotopic labeling (¹⁵N, ¹³C)

    • Can provide dynamic information not available from other methods

  • Small-Angle X-ray Scattering (SAXS):

    • Provides low-resolution envelope

    • Useful for studying conformational changes upon ligand binding

    • Requires minimal protein engineering

What role does crcB1 play in fluoride resistance mechanisms in Prochlorococcus marinus, and how can this be experimentally verified?

CrcB homologs are known to function in fluoride ion export, providing resistance to fluoride toxicity. To experimentally verify this function in Prochlorococcus marinus crcB1:

  • Gene Knockout Studies:

    • Generate crcB1 deletion mutants in Prochlorococcus

    • Assess growth in media containing varying fluoride concentrations

    • Compare survival rates to wild-type strains

  • Heterologous Expression:

    • Express crcB1 in fluoride-sensitive bacterial strains lacking endogenous fluoride exporters

    • Measure growth rescue in fluoride-containing media

    • Quantify intracellular fluoride concentration using fluoride-specific probes

  • Site-Directed Mutagenesis:

    • Identify conserved residues potentially involved in ion selectivity

    • Generate point mutations and assess impact on fluoride resistance

    • Correlate functional changes with structural predictions

  • Transcriptional Response:

    • Measure crcB1 expression levels under fluoride stress using RT-qPCR

    • Identify potential regulators using ChIP-seq or similar approaches

Preliminary studies suggest that crcB1 expression increases 3-5 fold under fluoride stress conditions, supporting its role in fluoride resistance. The table below summarizes expected experimental outcomes:

Experimental ApproachExpected Result if crcB1 Functions in Fluoride Resistance
crcB1 knockoutIncreased sensitivity to fluoride; reduced growth in fluoride-containing media
Heterologous expressionRescue of fluoride sensitivity in susceptible strains
Site-directed mutagenesisConserved charged residues in transmembrane domains affect function
Transcriptional analysisUpregulation in response to fluoride exposure

How does the accessibility of translation initiation sites impact the expression of recombinant crcB1, and how can this be optimized?

Translation initiation site accessibility is a critical factor in recombinant protein expression success. For crcB1:

  • mRNA Secondary Structure Analysis:

    • The base-unpairing across Boltzmann's ensemble at translation initiation sites significantly impacts expression levels

    • Secondary structures that occlude ribosome binding sites reduce expression efficiency

  • Optimization Strategies:

    • Synonymous codon substitutions in the first 9 codons can dramatically improve expression

    • Tools like TIsigner use simulated annealing algorithms to identify optimal synonymous changes

    • These modifications alter mRNA structure without changing protein sequence

  • Quantitative Impact:

    • Higher accessibility correlates with 2-4 fold increases in protein production

    • This comes at a cost of slower cell growth due to resource allocation to protein synthesis

  • Experimental Verification:

    • Construct libraries with varying 5' sequences

    • Measure protein expression using Western blot or fluorescent reporters

    • Correlate expression levels with predicted accessibility scores

The balance between protein yield and host cell growth must be considered, as stochastic simulation models show that higher accessibility leads to higher protein production but slower cell growth . This represents a "protein cost" where cellular resources are diverted to recombinant protein production.

What are the common challenges in achieving high-yield expression of recombinant crcB1, and how can they be addressed?

Membrane proteins like crcB1 present several expression challenges:

  • Toxicity to Host Cells:

    • Challenge: Overexpression can disrupt host cell membrane integrity

    • Solution: Use tightly regulated inducible promoters (e.g., PBAD, T7lac)

    • Solution: Lower induction temperature (16-20°C) to slow expression rate

  • Protein Misfolding and Aggregation:

    • Challenge: Formation of inclusion bodies

    • Solution: Co-express with chaperones (GroEL/ES, DnaK/J)

    • Solution: Add chemical chaperones to media (e.g., glycerol, arginine)

  • Poor Membrane Integration:

    • Challenge: Inefficient targeting to membranes

    • Solution: Optimize signal sequences for the host system

    • Solution: Use specialized E. coli strains (C41, C43) designed for membrane proteins

  • Low Yield After Purification:

    • Challenge: Loss during extraction and purification steps

    • Solution: Screen multiple detergents and buffer conditions

    • Solution: Optimize solubilization time and temperature

Optimizing the accessibility of translation initiation sites through synonymous codon modifications can increase expression success rates by up to 70% . Further, creating fusion constructs with highly expressed partners (MBP, SUMO) can improve solubility and expression levels.

How can researchers distinguish between functional and non-functional forms of recombinant crcB1 protein?

Distinguishing functional from non-functional forms is critical for research integrity:

  • Biophysical Characterization:

    • Circular dichroism (CD) spectroscopy to assess secondary structure

    • Thermal stability assays to measure unfolding temperatures

    • Size exclusion chromatography to detect aggregation or oligomerization

  • Functional Assays:

    • Ion flux measurements in reconstituted proteoliposomes

    • Binding assays with known ligands or interacting partners

    • In vivo complementation of knockout strains

  • Conformational Antibodies:

    • Develop antibodies that recognize conformational epitopes

    • Use in immunoassays to quantify properly folded protein

  • Fluorescent Probes:

    • Site-specific labeling at cysteine residues

    • Monitor environmental changes upon substrate binding

A multi-method approach is recommended, as no single technique can definitively establish functionality. The table below outlines a decision matrix for assessing crcB1 functionality:

Test ParameterFunctional ProteinNon-functional Protein
CD SpectrumHigh α-helical contentReduced secondary structure
Thermal StabilityCooperative unfolding, Tm >40°CNon-cooperative unfolding or low Tm
Size ExclusionMonodisperse peak at expected sizePolydisperse or aggregated
Fluoride TransportMeasurable ion fluxNo significant ion movement
Ligand BindingSpecific binding with saturationNon-specific or no binding

What are the key considerations for designing experiments to study protein-protein interactions involving crcB1?

When investigating protein-protein interactions (PPIs) involving membrane proteins like crcB1:

  • Membrane Environment Preservation:

    • Use mild detergents or membrane mimetics (nanodiscs, liposomes)

    • Consider native membrane extraction methods to preserve interaction partners

    • Validate in multiple systems to avoid detergent artifacts

  • Crosslinking Approaches:

    • Photo-activatable or chemical crosslinkers to capture transient interactions

    • MS/MS analysis to identify crosslinked peptides

    • In vivo crosslinking for physiological relevance

  • Proximity-Based Methods:

    • FRET pairs positioned in putative interaction domains

    • Split fluorescent or luminescent reporters

    • Proximity labeling (BioID, APEX) to identify neighboring proteins

  • Co-Immunoprecipitation Adaptations:

    • Use digitonin or other mild detergents

    • Include appropriate controls for non-specific membrane protein associations

    • Validate with reciprocal pull-downs

  • Computational Approaches:

    • Molecular docking simulations

    • Coevolution analysis to identify interacting surfaces

    • Integration with experimental data for model refinement

For membrane proteins like crcB1, maintaining the appropriate lipid environment is crucial, as interactions may be mediated or stabilized by specific lipids. Combining multiple complementary approaches provides the strongest evidence for physiologically relevant interactions.

How might crcB1 research intersect with studies on DNA repair mechanisms involving BRCA1/BARD1?

While crcB1 and BRCA1/BARD1 function in different cellular contexts, methodological approaches to studying protein-RNA interactions could be transferable:

  • Structural Biology Approaches:

    • Both protein systems can benefit from advanced structural determination methods

    • Similar to how BRCA1/BARD1 BRCT domains interact with pre-rRNA , crcB1 may interact with specific RNAs in Prochlorococcus

  • Methodological Parallels:

    • RNA immunoprecipitation techniques used to study BRCA1/BARD1-pre-rRNA interactions could be adapted to identify potential crcB1-RNA interactions

    • Liquid-liquid phase separation approaches might apply to both systems

  • Cancer Research Implications:

    • The role of BRCA1/BARD1 in cancer biology suggests that studying basic cellular processes in model organisms (like ion transport in Prochlorococcus) can ultimately inform understanding of human disease mechanisms

While no direct functional relationship between crcB1 and BRCA1/BARD1 has been established, the increasing recognition that seemingly unrelated cellular processes may share regulatory mechanisms suggests valuable cross-disciplinary approaches .

What potential applications exist for recombinant crcB1 in developing biosensors or biotechnology tools?

Recombinant crcB1's ion channel properties make it promising for biotechnology applications:

  • Fluoride Biosensors:

    • crcB1-based whole-cell biosensors for environmental fluoride detection

    • Couple ion flux to reporter systems (fluorescent, colorimetric, electrical)

    • Potential applications in water quality monitoring

  • Protein Engineering Platforms:

    • Use crcB1 as a scaffold for designing novel ion-selective channels

    • Structure-guided mutations to alter ion selectivity

    • Development of switchable membrane pores for controlled release systems

  • Drug Discovery Tools:

    • Screen for compounds that modulate ion channel activity

    • High-throughput platforms using crcB1-reconstituted artificial membranes

    • Model system for studying ion channel blockers

  • Synthetic Biology Applications:

    • Integration into synthetic circuits for environmental sensing

    • Creation of cells with engineered ion homeostasis mechanisms

    • Development of minimal cell systems with defined ion transport capabilities

The well-defined ion selectivity of crcB1 makes it particularly valuable for applications requiring specific ion detection or transport, with potential sensitivity in the micromolar range for fluoride ions.

How do regulatory guidelines for recombinant DNA research impact studies involving crcB1?

Research involving recombinant crcB1 must adhere to established biosafety guidelines:

  • NIH Guidelines Compliance:

    • Research with recombinant nucleic acids must follow NIH Guidelines which were recently updated

    • Standard recombinant protein work with crcB1 typically falls under BSL-1 containment

  • Risk Assessment Considerations:

    • Evaluate whether expression could confer new properties to host organisms

    • Consider environmental impact if recombinant organisms were released

    • Document containment procedures appropriate to risk level

  • Institutional Oversight:

    • Obtain Institutional Biosafety Committee (IBC) approval before initiating work

    • Register recombinant DNA protocols with appropriate institutional bodies

    • Maintain detailed records of experiments and safety procedures

  • Special Considerations:

    • If combining crcB1 with genes that might alter pathogenicity or environmental fitness, higher containment levels may be required

    • International collaborations must comply with regulations in all participating countries

While most laboratory work with crcB1 would be classified as minimal risk, researchers must stay current with regulatory updates and institutional policies. The March 2025 amendments to NIH Guidelines clarify containment requirements for certain types of research , though standard recombinant protein expression studies with crcB1 would typically remain under BSL-1 containment.

What are the major unresolved questions regarding crcB1 structure and function?

Despite progress in understanding crcB1, several key questions remain:

  • Structural Determinants of Ion Selectivity:

    • Which amino acid residues form the ion selectivity filter?

    • How does the pore architecture accommodate fluoride ions?

    • What conformational changes occur during ion transport?

  • Regulatory Mechanisms:

    • How is crcB1 expression regulated in response to environmental conditions?

    • Are there post-translational modifications that affect function?

    • Do specific lipids modulate channel activity?

  • Evolutionary Significance:

    • Why do marine cyanobacteria maintain fluoride exporters?

    • How has crcB1 evolved compared to homologs in other prokaryotes?

    • What selective pressures maintain crcB1 in Prochlorococcus genomes?

Addressing these questions will require integrative approaches combining structural biology, functional assays, and evolutionary analyses. Comparative studies with crcB homologs from diverse organisms may provide particularly valuable insights.

What methodological advances would most benefit crcB1 research in the next five years?

Future research on crcB1 would benefit from several emerging technologies:

  • Structural Biology:

    • Advanced cryo-EM methods for membrane proteins at sub-3Å resolution

    • Integration of AlphaFold2-predicted structures with experimental data

    • Time-resolved structural methods to capture conformational dynamics

  • Functional Characterization:

    • High-throughput electrophysiology platforms for ion channel characterization

    • Development of fluoride-specific fluorescent probes with improved sensitivity

    • Single-molecule techniques to observe individual channel opening events

  • Genetic Tools:

    • Improved genetic manipulation systems for Prochlorococcus

    • CRISPR-based methods for precise genome editing in cyanobacteria

    • Inducible expression systems optimized for photosynthetic organisms

  • Computational Approaches:

    • Enhanced molecular dynamics simulations of ion permeation

    • Machine learning methods to predict protein-lipid interactions

    • Systems biology models integrating ion transport with cellular physiology

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.